GlassScriptPhysician profile
William Todd Sherrer
NPI 1831189158
$11,228.82
in general payments reported to CMS, 2019-2025
42 companies · $934 in 2025
The $934 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,290 · 2020: $712 · 2021: $878 · 2022: $2,074 · 2023: $1,536 · 2024: $805 · 2025: $934.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,275.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,274.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,924.02 | 2019-2025 | Aquabeam System |
| Dendreon Pharmaceuticals LLC | $1,447.40 | 2019-2024 | Provenge |
| Boston Scientific Corporation | $1,081.71 | 2019-2023 | |
| Janssen Biotech, INC. | $827.10 | 2019-2025 | Erleada, Akeega, Balversa |
| Astellas Pharma US INC | $779.85 | 2019-2024 | Xtandi |
| Sumitomo Pharma America, INC. | $641.29 | 2023-2025 | Gemtesa, Orgovyx |
| Bayer Healthcare Pharmaceuticals INC. | $559.90 | 2021-2025 | |
| Urogen Pharma, INC. | $386.22 | 2020-2025 | Jelmyto |
| Antares Pharma, INC. | $328.62 | 2020-2023 | Nocdurna, Tlando, Xyosted |
| Abbvie INC. | $317.39 | 2020-2025 | Botox, Lupron Depot |
| Myriad Genetic Laboratories, INC. | $280.98 | 2021-2025 | Prolaris |
| Intuitive Surgical, INC. | $265.14 | 2019-2020 | |
| Neotract INC. | $235.39 | 2019-2020 | |
| Urovant Sciences INC | $222.84 | 2021-2022 | |
| Coloplast Corp | $212.39 | 2019-2025 | Speedicath |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Sherrer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.